Active Ingredient History

NOW
  • Now
Sovaprevir is an experimental drug designed to treat the hepatitis C virus. It is under development by Achillion Pharmaceuticals. It acts as a NS3/4A inhibitor.Sovaprevir received fast track status from the U.S. Food and Drug Administration in 2012.   Wikipedia

  • SMILES: COc1ccc2c(O[C@@H]3C[C@H](N(C3)C(=O)[C@@H](CC(=O)N4CCCCC4)C(C)(C)C)C(=O)N[C@@]5(C[C@H]5C=C)C(=O)NS(=O)(=O)C6CC6)cc(nc2c1)c7ccccc7
  • InChIKey: MHFMTUBUVQZIRE-WINRQGAFSA-N
  • Mol. Mass: 799.99
  • ALogP: 4.99
  • ChEMBL Molecule:
More Chemistry
ach-0141625 | sovaprevir

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue